Results 161 to 170 of about 2,484 (221)

Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology. [PDF]

Biochem Pharmacol
Agoulnik IU, Kaftanovskaya EM, Myhr C, Bathgate RAD, Kocan M, Peng Y, Lindsay RM, DiStefano PS, Agoulnik AI.   +8 more
europepmc   +1 more source

R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases [PDF]

Bruno Poirier, Olivier Pasquier, Xavier Chénedé, Alain Corbier, Philippe Prigent, Aurélien Azam, Carine Bernard, Michel Guillotel, F Gillot, Laurence Riva, Véronique Briand, Raffaele Ingenito, Laurence Gauzy‐Lazo, Olivier Duclos, Christophe Philippo, Bernard Maillère, Elisabetta Bianchi, Sergio Mallart, Philip Janiak, Stéphane Illiano   +19 more
openalex   +1 more source

G protein-coupled receptors in prostate cancer: research progress and therapeutic targets. [PDF]

Front Cell Dev Biol
Xiong W, Zhou B, Shi J, Ni D, Xiong Z.
europepmc   +1 more source

Relaxin-2-secreting CAR-T cells exhibit enhanced efficacy in stromal-rich xenograft tumors. [PDF]

Front Immunol
Ogawa H, Ekawa T, Mizote Y, Akazawa T, Tahara H.   +4 more
europepmc   +1 more source

KIAA1429 in non-small cell lung cancer: bridging m6A epigenetics to therapeutic innovation. [PDF]

Front Surg
Liu H, Shi K, Liu L, You BH, Liu T, Ren XF, Guo Q, Li D.   +7 more
europepmc   +1 more source

Diet-Driven Microglial Activation: Region-Specific Neuroinflammation in the Mouse Brain. [PDF]

Brain Sci
Plantera L, Bernhart SH, Immig K, Leyh J, Ceglarek U, Bechmann I.   +5 more
europepmc   +1 more source

Relaxin-2 Exhibits a Beneficial Role in Energy Metabolism to Alleviate Atrial Fibrillation Susceptibility. [PDF]

ACS Pharmacol Transl Sci
Zhao X, Cao Y, Gao Q, Han X, Zhang H, Mu H, Zhang S, Wang X, Li Y, Yuan Y.   +9 more
europepmc   +1 more source

Development of Diphenyl-1,2,4-Oxadiazole Analogues as Allosteric Modulators of the RXFP3 Receptor: Evaluation of Importance of the N-Substituted-2-Pyrrolidone Moiety in RLX-33. [PDF]

J Med Chem
Guan D, Chaminda Lakmal HH, Bender BN, Rahman MT, Gay EA, Barrus DG, Mosera AM, Kerr AT, Besheer J, Jin C.   +9 more
europepmc   +1 more source

Deciphering complexity of GPCR signaling and modulation: implications and perspectives for drug discovery. [PDF]

Clin Sci (Lond)
Costa-Neto CM, Parreiras-E-Silva LT.
europepmc   +1 more source

Sequential targeted therapy in synchronous dual-primary lung adenocarcinomas with EGFR and RET alterations: a 5-year follow-up case report. [PDF]

Front Oncol
Niu YL, Yang Y, Teng XB, Han MF, Wang DM.   +4 more
europepmc   +1 more source